Open Access
Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways
Author(s) -
Xiaolin Huang,
Chao Liu,
Xuemei Shi,
YuTing Cheng,
Qian Zhou,
Jianping Li,
Jian Liao
Publication year - 2021
Publication title -
molecular medicine reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.727
H-Index - 56
eISSN - 1791-3004
pISSN - 1791-2997
DOI - 10.3892/mmr.2021.12575
Subject(s) - rankl , osteoclast , chemistry , nf κb , microbiology and biotechnology , bone resorption , activator (genetics) , signal transduction , rank ligand , kinase , cellular differentiation , cancer research , biochemistry , biology , receptor , endocrinology , gene